Skip to main content
Helen Ross, MD, Oncology, Chicago, IL

HelenJRossMD(She/Her)

Oncology Chicago, IL

Thoracic Cancer

Thoracic Medical Oncology Professor of Internal Medicine Chief, Division of Hematology, Oncology and Cellular Therapy Director of Research and Clinical Trials Rush University Cancer Center

Dr. Ross is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ross' full profile

Already have an account?

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1990
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterResidency, Internal Medicine, 1984 - 1987
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1984

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2023 - 2026
  • AZ State Medical License
    AZ State Medical License 2007 - 2025
  • CA State Medical License
    CA State Medical License 1985 - 2025
  • OR State Medical License
    OR State Medical License 1997 - 2025
  • CO State Medical License
    CO State Medical License 2022 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Phase II trial of atezolizumab before and after definitive chemoradiation for unresectable stage III NSCLC. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Press Mentions

  • Double Cancer Diagnosis Leads Arizona Couple to Mayo Clinic for Care
    Double Cancer Diagnosis Leads Arizona Couple to Mayo Clinic for CareDecember 3rd, 2017
  • Mesothelioma Patient Finds Complex, Comprehensive Answer
    Mesothelioma Patient Finds Complex, Comprehensive AnswerJuly 12th, 2017

Grant Support

  • Cyclosporine Enhancement Of Paclitaxel In Lung CancerNational Cancer Institute1997–1999
  • Cyclosporine Enhancement Of Paclitaxel In Lung CancerNational Cancer Institute1996–1997
  • Regulation Of Cytokine MRNA Stability In Tumor CellsNational Cancer Institute1991–1995

Professional Memberships